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Introduction 
SOX10 is a commonly used marker for the diagnosis 
of melanocytic neoplasms on formalin sections. It 
can also be used on frozen sections for rapid 
immunohistochemical margin assessment. Initial 
reports suggested SOX10 immunostaining could 
reliably distinguish amelanotic melanoma from 
dermal scar and fibrohistiocytic processes [1, 2]. 
However, more recently published data on formalin 
sections indicate that SOX10 frequently stains scar [3, 
4]. In our practice, several cases of melanoma in situ, 
lentigo maligna (LM-MIS) type were found during 
Mohs micrographic surgery (MMS) to have SOX10-
positive, MART-1-negative cells in the dermis 
without findings suspicious for invasive melanoma 
on hematoxylin and eosin sections. Tissue from these 
cases was submitted for formalin processing and 
formal dermatopathology review and considered 
scar. To better characterize the propensity for SOX10 
to label scar on frozen sections, we stained a series of 
non-melanocytic MMS cases with SOX10. 
A total of 31 MMS specimens (all keratinocyte 
carcinoma cases) showing regions of thickened 
collagen bundles and stellate fibroblasts consistent 
with scar on frozen section hematoxylin and eosin 
were included. These de-identified specimens had 
additional sections cut at 4μm and were stained with 
a modified, rapid, immunohistochemical protocol for 
SOX10 (Biocare, mouse monoclonal antibody at 1:50 
dilution) with a negative control [5]. Endogenous 
peroxidase blocking was performed on all specimens 
prior to primary antibody incubation and no SOX10 
staining was seen in negative control specimens. 
Of the 31 specimens, 11 showed SOX10 staining of 
presumed fibrohistiocytic cells within scar in sections 
without any suspicion for a melanocytic process in 
dermis. Staining of dermal spindled cells was strong 
but fractional relative to the overall cellularity of scar 
on hematoxylin and eosin as seen in Figure 1. These 
findings conflict with prior reports touting the 
specificity of SOX10 for desmoplastic melanoma [1, 
2]. Our data further corroborate recent reports from 
the dermatopathology literature finding that non-
melanocyte SOX10 staining is commonly seen in re-
excision specimens [3, 4]. These SOX10-positive cells 
are presumably fibrohistiocytic, although the 
fractional staining seen in cellular scar may suggest a 
distinct lineage of these cells. SOX10 staining of 
Abstract 
Sox10 immunostaining is used for the diagnosis and 
margin evaluation of melanocytic lesions. Sox10 was 
initially thought not to stain fibrohistiocytic 
processes. Consequently, it was believed to reliably 
distinguish desmoplastic melanoma from scar. 
However, recent data from formalin sections suggest 
Sox10 is less specific than previously thought. In this 
report, we demonstrate that Sox10-stained Mohs 
sections commonly show strong, fractional staining 
of scar. When using Sox10 with frozen section 
immunohistochemistry, Mohs practitioners should 
recognize the potential of this marker to stain scar to 
avoid overdiagnosis of desmoplastic melanoma. 
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regenerating Schwannian cells has also been 
hypothesized [4]. 
 
Conclusion 
SOX10 is a melanocytic antigen used for the 
diagnosis and margin assessment of melanocytic 
neoplasms. This nuclear marker may be useful to 
better appreciate the true density of melanocytes 
that may be overestimated by MART-1 dendritic 
staining on heavily sun-damaged skin. However, 
when using SOX10 during MMS for melanoma, it is 
important to recognize that this marker frequently 
stains scar on rapid frozen sections. Caution should 
be used when interpreting dermal SOX10-positive 
cells as invasive or desmoplastic melanoma in the 
absence of corroborating evidence on hematoxylin 
and eosin. The morphology of these cells on H/E may 
assist in categorizing the malignant potential of 
these findings [4]. Submitting LM-MIS cases with 
SOX10-positive dermal proliferations for formalin 
processing and assessment may allow more precise 
morphologic categorization of such proliferations. 
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Figure 1. A) Mohs hematoxylin and eosin section showing 
cellular scar, 10×. B) The same Mohs SOX10-stained section 
showing fractional staining of cells, 10×. 
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